90 related articles for article (PubMed ID: 4990188)
1. [Immunologic studies in the lymphocyte culture after high voltage radiotherapy or high-dosage cytostatic therapy and bone marrow transplantation].
Stinner G; zur Horst-Meyer H
Z Gesamte Inn Med; 1969 Jan; 24(1):Suppl:116-7. PubMed ID: 4990188
[No Abstract] [Full Text] [Related]
2. [Immunologic investigations in lymphocyte culture following intensive radiotherapy or high dosage cytostatic massive therapy and bone marrow transplantations].
Stinner G; zur Horst-Meyer H
Z Gesamte Inn Med; 1969 Apr; 24(8):Suppl:116-7. PubMed ID: 4895708
[No Abstract] [Full Text] [Related]
3. Establishment of complete and mixed donor chimerism after allogeneic lymphohematopoietic transplantation: recommendations from a workshop at the 2001 Tandem Meetings of the International Bone Marrow Transplant Registry and the American Society of Blood and Marrow Transplantation.
Antin JH; Childs R; Filipovich AH; Giralt S; Mackinnon S; Spitzer T; Weisdorf D
Biol Blood Marrow Transplant; 2001; 7(9):473-85. PubMed ID: 11669214
[TBL] [Abstract][Full Text] [Related]
4. Induction of stable long-term mixed hematopoietic chimerism following nonmyeloablative conditioning with T cell-depleting antibodies, cyclophosphamide, and thymic irradiation leads to donor-specific in vitro and in vivo tolerance.
Mapara MY; Pelot M; Zhao G; Swenson K; Pearson D; Sykes M
Biol Blood Marrow Transplant; 2001; 7(12):646-55. PubMed ID: 11787527
[TBL] [Abstract][Full Text] [Related]
5. [Bone marrow transplantation. 1. Treatment of medullary aplasias].
Perreault C; Boileau J; Bonny Y; d'Angelo G; Gyger M; Lacombe M; Lavallée R
Union Med Can; 1981 Mar; 110(3):264-8. PubMed ID: 7018046
[No Abstract] [Full Text] [Related]
6. [Transplantation of preserved bone marrow during the inhibition of hematopoiesis in oncologic patients].
Pushkar' NS; Nakonechnyĭ AA; Shenberg MG; Simonova LI; Pashchenko NS
Klin Khir (1962); 1972 May; 5():55-7. PubMed ID: 4557861
[No Abstract] [Full Text] [Related]
7. [High-dosage cytostatic therapy and autologous bone marrow reinfusion in malignant tumors. Current experience of the Viennese workshop on chemotherapy of malignant tumors].
Mannheimer E; Karrer K; Boeckl O; Priesching A
Munch Med Wochenschr; 1967 Sep; 109(35):1808-13. PubMed ID: 5240395
[No Abstract] [Full Text] [Related]
8. Lymphocyte reconstitution after allogeneic bone marrow transplantation in a previously thymectomized patient--no evidence of extrathymic T-cell maturation.
Giebel S; Dziaczkowska J; Wysoczanska B; Wojnar J; Krawczyk-Kulis M; Lange A; Holowiecki J
Bone Marrow Transplant; 2007 Oct; 40(7):705-6. PubMed ID: 17680024
[No Abstract] [Full Text] [Related]
9. Human donor bone marrow cells can enhance hyporeactivity in renal transplantation using maintenance FK 506 and OKT3 induction therapy.
Ciancio G; Carreno M; Mathew J; Ricordi C; Garcia R; Karatzas T; Fuller L; Cirocco R; Burke G; Webb M; Nery J; Tzakis A; Roth D; Esquenazi V; Miller J
Transplant Proc; 1996 Apr; 28(2):943-4. PubMed ID: 8623473
[No Abstract] [Full Text] [Related]
10. Successful pregnancy after high dose chemotherapy and marrow transplantation for treatment of aplastic anemia.
Card RT; Holmes IH; Sugarman RG; Storb R; Thomas ED
Exp Hematol; 1980 Jan; 8(1):57-60. PubMed ID: 6997062
[TBL] [Abstract][Full Text] [Related]
11. [Medullotherapy in hematopoietic depression].
Sherman SI; Shabalin VN; Abdulkadyrov KM
Vopr Onkol; 1980; 26(2):3-7. PubMed ID: 6767309
[TBL] [Abstract][Full Text] [Related]
12. [Use of allomyelotransplantation in the therapy of hempoietic hypoklasia caused by cytostatic preparations].
Mikhaĭlov VG; Alieva TM; Olender SK; Glindeman VP
Probl Gematol Pereliv Krovi; 1972 Mar; 17(3):25-7. PubMed ID: 4618606
[No Abstract] [Full Text] [Related]
13. [Clinico-immunologic problems of bone marrow transplantation].
Faĭnshteĭn FE; Zotikov EA
Probl Gematol Pereliv Krovi; 1966 Feb; 11(2):3-6. PubMed ID: 4863867
[No Abstract] [Full Text] [Related]
14. [Therapy using immunosuppressive agents following clinical transplantation of bone marrow].
Silobrcić V
Lijec Vjesn; 1978 Jun; 100(6):394-5. PubMed ID: 359982
[No Abstract] [Full Text] [Related]
15. Eosinophilia after allogeneic bone marrow transplantation using busulfan and cyclophosphamide conditioning regimen.
Arslan O; Akan H; Koç H; Beksaç M; Ilhan O; Ozcan M; Yalçín S; Gürman G; Konuk N; Uysal A
Bone Marrow Transplant; 1996 Jul; 18(1):261. PubMed ID: 8832034
[No Abstract] [Full Text] [Related]
16. Treatment of diffuse alveolar hemorrhage after allogeneic bone marrow transplant with recombinant factor VIIa.
Hicks K; Peng D; Gajewski JL
Bone Marrow Transplant; 2002 Dec; 30(12):975-8. PubMed ID: 12476294
[TBL] [Abstract][Full Text] [Related]
17. Rapamycin and T cell costimulatory blockade as post-transplant treatment promote fully MHC-mismatched allogeneic bone marrow engraftment under irradiation-free conditioning therapy.
Wu T; Sozen H; Luo B; Heuss N; Kalscheuer H; Lan P; Sutherland DE; Hering BJ; Guo Z
Bone Marrow Transplant; 2002 Jun; 29(12):949-56. PubMed ID: 12098061
[TBL] [Abstract][Full Text] [Related]
18. Low dose-rate irradiation in the treatment of acute myelogenous leukaemia in first remission.
Cattell PA; Unwin SF
Radiography; 1981 Apr; 47(556):101-4. PubMed ID: 7025088
[No Abstract] [Full Text] [Related]
19. [Homo- and autotransplantation of bone marrow in radiation and chemotherapy of oncologic patients].
Gnatyshak AI; Loginskiĭ VE; Mazurok AA
Vrach Delo; 1973 Apr; 4():129-32. PubMed ID: 4576249
[No Abstract] [Full Text] [Related]
20. Is blood or bone marrow better?
Kessinger A
Stem Cells; 1993 Jul; 11(4):290-5. PubMed ID: 8104616
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
